Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/72732
|Title:||Dosimetric comparison of T-O brachytherapy with/without interstitial component in FIGO I-IIB tumors||Authors:||Federico, M.
Perez Fustero, A.
Perez Molina, J. L.
Morales Orue, I.
Lloret Sáez-Bravo, Marta
|UNESCO Clasification:||320111 Radiología||Issue Date:||2019||Journal:||Radiotherapy and Oncology||Conference:||38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)||Abstract:||Purpose or Objective: Intracavitary/interstitial (IC/IS) brachytherapy (BT) improves HRCTV dose coverage in large locally advanced tumors resulting in improved local control and survival. In small tumors IC/IS brachytherapy may be useful in selected situations due to difficult OAR/tumor topography. A prospective trial was designed in order to evaluate in a series of consecutive patients with small cervical tumors potential gains of IC/IS vs. Intracavitary (IC) brachytherapy||URI:||http://hdl.handle.net/10553/72732||ISSN:||0167-8140||DOI:||10.1016/S0167-8140(19)30593-6||Source:||Radiotherapy And Oncology [ISSN 0167-8140], v. 133 sup. 1, p. S85-S86, (Abril 2019)|
|Appears in Collections:||Actas de congresos|
checked on May 23, 2020
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.